Evidence map›Paper›PMID 30056528›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2019

Family caregiver descriptions of stopping chemotherapy and end-of-life transitions.

S A Norton, M N Wittink, P R Duberstein, H G Prigerson, S Stanek, R M Epstein

Open access · greenAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Aggressiveness of end-of-life cancer care: what happens in clinical practice?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  14. Article
  15. Article
  16. The impact of the caregiver-oncologist relationship on caregiver experiences of end-of-life care and bereavement outcomes.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

S A NortonSchool of Nursing, University of Rochester, Rochester, NY, USA. Sally_Norton@urmc.rochester.edu.ORCID http://orcid.org/0000-0001-7686-6327
M N WittinkDepartment of Family Medicine, University of Rochester, Rochester, NY, USA.
P R DubersteinDepartment of Medicine, Division of Palliative Care, University of Rochester, Rochester, NY, USA.
H G PrigersonDepartment of Medicine, Weill Cornell Medicine, New York, NY, USA.
S StanekSchool of Nursing, University of Rochester, Rochester, NY, USA.
R M EpsteinDepartment of Medicine, Division of Palliative Care, University of Rochester, Rochester, NY, USA.
University of Rochester · USCornell University · USUniversity of Rochester Medical Center · US

Funding

Psychosocial Approaches to Better Understanding & End-Stage Cancer Care (PROTECT)R35CA197730 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Holly Gwen Prigerson · 2015 to 2026
$11.2M
RCT of Patient, Caregiver and Physician Communication Coaching in Advanced CancerR01CA140419 · NCI · UNIVERSITY OF ROCHESTER · PI EPSTEIN, RONALD M., KRAVITZ, RICHARD L · 2011 to 2015
$2.7M
Impact of a Novel Cancer Communication Intervention on Caregiver BereavementR01CA168387 · NCI · UNIVERSITY OF ROCHESTER · PI DUBERSTEIN, PAUL R, PRIGERSON, HOLLY GWEN · 2013 to 2017
$2.6M
National Cancer Institute R01CA1404191National Cancer Institute R01CA168387NCI NIH HHS R01 CA140419NCI NIH HHS R01 CA168387NCI NIH HHS R35 CA197730
6 · The paper itself

Abstract

purposeThe purpose of this study was to describe family caregivers' perspectives of the final month of life of patients with advanced cancer, particularly whether and how chemotherapy was discontinued and the effect of clinical decision-making on family caregivers' perceptions of the patient's experience of care at the end of life (EOL).

methodsQualitative descriptive design using semi-structured interviews collected from 92 family caregivers of patients with end-stage cancer enrolled in a randomized clinical trial. We used a phased approach to data analysis including open coding, focused coding, and within and across analyses.

resultsWe identified three patterns of transitions characterizing the shift away from active cancer treatment: (1) "We Pretty Much Knew," characterized by explicit discussions about EOL care, seemingly shared understanding about prognosis and seamless transitions from disease-oriented treatment to comfort-oriented care, (2) "Beating the Odds," characterized by explicit discussions about disease-directed treatment and EOL care options, but no shared understanding about prognosis and often chaotic transitions to EOL care, and (3) "Left to Die," characterized by no recall of EOL discussions with transitions to EOL occurring in crisis.

conclusionsAs communication and palliative care interventions continue to develop to improve care for patients with advanced cancer, it is imperative that we take into account the different patterns of transition and their unique patient and caregiver needs near the end of life. Our findings reveal considerable, and potentially unwarranted, variation in transitions from active treatment to death.

Indexed as

AdultAgedAged, 80 and overCaregiversCommunicationDecision MakingFemaleHumansMaleMiddle AgedNeoplasmsPrognosisQuality of LifeSurvival AnalysisTerminal CareYoung AdultCancerCaregiverCommunicationDecision-makingEnd of lifePalliative carePrognosis

Identifiers

PMID30056528
PMCPMC6338326
OpenAlexW2883660196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.